🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 80% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size
45 Servings
Other Combinations Product Type
80% Evidence Coverage

Supplement Facts — Evidence Check

35 mg (8% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 35mg
10 mg (91% DV)
✅ Within RDA (0.9× RDA of 11 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 10mg UL 40mg
L-Glycine
500 mg
300 mg
📊 Market median: 200.0mg (358 products) 📚 9 studies (Tier A: 0, B: 2)
This product: 300mg
150 mg
📊 Market median: 400.0mg (73 products) 📚 12 studies (Tier A: 0, B: 5)
This product: 150mg UL 250mg

Other Ingredients

Cellulose Ascorbyl Palmitate Silicon Dioxide Microcrystalline Cellulose

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Children 4 or More Years of Age Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested use: Adults take 2 capsules in the AM 30 minutes before or after a meal and if needed 2-3 capsules in the evening. Children 5+ take 1 capsule daily or as recommended by your healthcare practitioner.

⚠️ Warnings & Precautions

Do not exceed 6 capsules daily.

Caution: If pregnant or lactating consult with your healthcare practitioner prior to use.

Keep out of reach of children.

Professional use only

🧪 Formulation Notes

This formula was designed to assist patients who have difficulty producing adequate amounts of GABA, an important brain neurotransmitter. GABA plays a role in reducing excitability throughout the nervous system, as well as regulation of muscle relaxation. Many patients possess a genetic mutation of GAD (Glutamic Acid Oecarboxylase), the primary enzyme that creates GABA. Weakness in the GAD enzyme creates an increased amount of Glutamate, the excitatory neurotransmitter, and a deficiency of GABA. This intolerance creates an overly stimulated nervous system.

The 5 key ingredients are designed to assist with: Nervousness or anxiousness Mood & muscle relaxation Difficulty falling or staying asleep Improved sense of well being

Mood support Mental relaxation

Professional grade

Product Details

UPC / SKU 8 58104 00620 2
DSLD Entry Date 2025-04-24
Product Type Other Combinations
Form Capsule
DSLD ID 327701
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →